GALDERMA LABORATORIES, L.P. – Trademark Portfolio
Entity Type: 13
GALDERMA LABORATORIES, L.P. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 7 trademarks are registered. Notable registered marks include BENZAC, DESOWEN, BENZAC W, CETAPHIL, and BENZAC AC. The owner is based in FORT WORTH, TX.
14501 NORTH FREEWAY
FORT WORTH, TX 76177
Showing of trademarks Trademarks
Trademark Classifications
GALDERMA LABORATORIES, L.P.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does GALDERMA LABORATORIES, L.P. have?
GALDERMA LABORATORIES, L.P. has 10 U.S. trademarks filed with the USPTO. Of these, 7 registered, 3 cancelled.
What trademark classes does GALDERMA LABORATORIES, L.P. file in?
GALDERMA LABORATORIES, L.P. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are GALDERMA LABORATORIES, L.P.'s most well-known trademarks?
GALDERMA LABORATORIES, L.P.'s registered trademark portfolio includes well-known marks such as BENZAC, DESOWEN, BENZAC W, CETAPHIL, and BENZAC AC. These are among 7 currently registered trademarks in the portfolio.
What is GALDERMA LABORATORIES, L.P.'s trademark registration success rate?
GALDERMA LABORATORIES, L.P. has a 70% trademark registration rate, with 7 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.